Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Aortic Diseases
4.2.2 Growing Adoption of Minimally Invasive Surgeries
4.2.3 Technoloigical Advancements in Development of Artificial Blood Vessels
4.3 Market Restraints
4.3.1 High Cost Associated with Transplants and Surgeries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Aortic Disease
5.1.2 Peripheral Artery Disease
5.1.3 Hemodialysis
5.2 By Polymer
5.2.1 Polydioxanone
5.2.2 Elastomer
5.2.3 Polyethylene Terephthalate
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen
6.1.2 Becton, Dickinson and Company
6.1.3 Cook Medical Incorporated
6.1.4 Humacyte Inc.
6.1.5 Jotec GmbH
6.1.6 LeMaitre Vascular Inc
6.1.7 Medtronic
6.1.8 Techshot Inc
6.1.9 Terumo Medical Corporation
6.1.10 W. L. Gore and Associates


7 MARKET OPPORTUNITIES AND FUTURE TRENDS